This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/russia/602822-world-first-allergy-vaccine-test/

The article has changed 2 times. There is an RSS feed of changes available.

Version 0 Version 1
Russia to test novel allergy treatment Russia to test new allergy vaccine
(about 5 hours later)
The new drug is designed to treat allergy to birch pollen much faster than existing methods The drug is designed to combat adverse reactions to birch pollen much faster than existing methods
Moscow will start testing the first-ever vaccine for allergies to birch pollen, according to Veronika Skvortsova, the head of Russia’s Federal Medical-Biological Agency (FMBA). 
Moscow will start testing the first-ever drug designed to cure allergy to birch pollen, according to Veronika Skvortsova, the head of Russia’s Federal Medical-Biological Agency (FMBA).  The vaccine is also designed to combat the effects of similar allergens, including apples, peaches, peanuts, and soy, Kommersant reported. Clinical trials announced last week are expected to start in September and be completed by next summer.  
According to the newspaper Kommersant, the drug is also designed to be used to treat the effects of “similar allergens,” such as apples, peaches, peanuts, and soy. The trial announced last week is expected to start in September and to be completed by summer 2024.   The vaccine developed by FMBA’s Immunology Institute along with the Medical University of Vienna could revolutionize allergen-specific immunotherapy, according to the researchers behind the project.
The drug developed by FMBA’s Immunology Institute together with the Medical University of Vienna could revolutionize the allergen-specific immunotherapy, according to the researchers behind the project. Existing treatments can take several years and involve dozens of shots, and still only end up reducing the symptoms rather than eliminating them completely. According to the researchers, the new vaccine would require just three to five shots to be effective. 
The existing treatments can take several years and involve dozens of shots, and still only end up reducing the symptoms rather than eliminating them completely. According to researchers, the new treatment would require just between three and five shots to be effective.  “We have charted the birch allergen and found the most important parts in its structure,” Igor Shilovsky, the deputy director for science and innovations at the Immunology Institute, said. He added that the parts responsible for toxicity and potential side effects were removed to create an anti-allergy vaccine.
“We have charted the birch allergen and found the most important parts in its structure,” said Igor Shilovsky, the deputy director for science and innovations at the Immunology Institute. He added that scientists removed the parts responsible for toxicity and potential side effects and created an anti-allergy “vaccine.”  In the 1990s, researchers determined that allergens are a group of proteins, which made allergen-specific therapy possible. The development of vaccines based on recombinant allergens and synthetic allergen peptides has been discussed since the 2010s. However, all known treatments require long periods of time to produce sustainable effects. 
In the 1990s, the researchers determined that allergens are a group of proteins, which made allergen-specific therapy possible. The development of vaccines based on recombinant allergens and synthetic allergen peptides has been discussed since the 2010s. Yet, all known treatments require a long time to produce sustainable effects.